Resources from the same session
47MO - Activating EZH2 mutations define a new subset of aggressive Ewing sarcomas
Presenter: Pawel Sobczuk
Session: Mini oral session
Resources:
Abstract
Slides
Webcast
48MO - Characteristics and outcomes of 76 patients with pleomorphic liposarcoma: The Gustave Roussy experience
Presenter: Tarek Assi
Session: Mini oral session
Resources:
Abstract
Slides
Webcast
49MO - Atezolizumab and bevacizumab in patients treated with prior atezolizumab in alveolar soft tissue sarcoma (ASPS)
Presenter: Alice Chen
Session: Mini oral session
Resources:
Abstract
124MO - A single centre experience of patients with rare cancers referred for early phase clinical trials
Presenter: Angelos Angelakas
Session: Mini oral session
Resources:
Abstract
Slides
Webcast
Invited discussant
Presenter: William D. Tap
Session: Mini oral session
Resources:
Slides
Webcast
28MO - Predictive biomarkers of response to axitinib in patients with advanced EP-NETs enrolled in the AXINET trial (GETNE 1107): Underlying molecular mechanisms
Presenter: Alberto Lens-Pardo
Session: Mini oral session
Resources:
Abstract
29MO - Germline variants NGS characterization in patients with non-syndromic adrenocortical carcinoma
Presenter: Salvatore Grisanti
Session: Mini oral session
Resources:
Abstract
Slides
Webcast
Invited discussant
Presenter: Agnieszka Kolasinska-Cwikla
Session: Mini oral session
Resources:
Slides
Webcast